It is very likely that at some time you have experienced twitching of the eyelids. If it has gone on for a while then you will know bothersome it can be. Twitching of the eyelids is caused by a contraction of the orbicularis muscle in the upper or lower eyelid. It may suddenly appear and […]
From September 10th-13th the XIII conference of the European Society of Neurophthalmology (EUNOS 2017) was held in Budapest, Hungary. The congress is a showcase for the latest advances in the fields of neurology and ophthalmology, with a special focus on pathophysiology and therapy. Amongst those attending were international experts in these fields, such as Dr. Lorena Castillo, […]
The 25th Conference of the Spanish Society of Paediatric Ophthalmolgy and Strabismus (SEEOP) was held from the 20th-22nd of April at the City of Leon Auditorium. Among those taking part in the event were ophthalmologists from the ICR’s Neuro-ophthalmology and Paediatric Ophthalmology Departments. Oral Presentations During the oral presentations section of the event, two presentations on neuro-ophthalmology were […]
On February 17th and 18th, the 10th refresher course on Neuro-ophthalmology took place in Madrid. It is a biannual event that has been celebrate during the last 18 years with the attendance of between 400 and 500 ophthalmologists. The aim of the course is to offer innovative information on action protocols regarding diagnosis and treatments […]
An editorial on LOHN therapeutic perspectives (Leber’s Hereditary Optic Neuropathy) from Dr Lorena Castillo, Head of Neuro-Ophthalmology Department at ICR, has been published in the December issue of the journal Archivos de la Sociedad Española de Oftalmología. Editorials in medical journals are published by leading specialists in a specific area, and are aimed at analyzing and […]
ICR, at the forefront of research Dr Castillo, Head of Neuro-Ophthalmology and Teaching Department at Institut Català de Retina, has initiated, alongside the Research Department, a clinical trial developed by Santhera Pharmaceuticals, for which participants affected by Leber Optic Neuropathy (LHON), older than 12 years old and of all genders, are being recruited. The disease must […]
